4
Changes in Ownership
Cocrystal Pharma, Inc. Filed Acc 0001493152-26-002036
Options or other derivatives
- Co-CEO and CFO acquired 49,229 shares (grant or award)
From the SEC's structured data for this filing
Cocrystal Pharma, Inc. Filed Acc 0001493152-26-002036
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…